History and Key Milestones
Hilleman Laboratories was established in 2009 in India is an equal joint venture between MSD, a global research-driven pharmaceutical company and Wellcome Trust Ltd, a global charitable foundation dedicated to human and animal health.
Initiation of phase II of a highly stable rotavirus vaccines in collaboration with MSD.
Announcement of collaboration with Gotovax AB-Sweden to develop a high impact oral cholera vaccine;
MoU signing with Bangladesh based ICDDR-B to fast track its clinical trials
MoU signing with Bangladesh based ICDDR-B to fast track its clinical trials
Preclinical success of meningococcal vaccine indicates predictive results, making new vaccines cost effective to meet the needs of developing countries
Out-licensing of meningococcal vaccine and Partner in Future Vaccine Manufacturing Hub at Imperial Collge London
Partnership with Bharat Biotech for development and commercialisation of Hillchol oral cholera vaccine